US Patent 9884054 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

Patent 9884054 was granted and assigned to Aragon Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Isan Chen0

Date of Patent

February 6, 2018

Patent Application Number

140344600

Date Filed

September 23, 2013

Patent Primary Examiner

Patent abstract

Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 9884054 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.